These patients with positive TEL-AML1 fusion who achieved a favorable prognosis were found to be younger, without hyperleukocyosis, with the CD 10 positive B precursor ALL immunophenotyping and chemosensitive [2]. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.